{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:01:32Z","timestamp":1761901292062,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.msard.2017.12.011","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T13:23:59Z","timestamp":1513603439000},"page":"25-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Pulmonary Sarcoidosis in a patient with Multiple Sclerosis on daclizumab monotherapy"],"prefix":"10.1016","volume":"20","author":[{"given":"Elijah Edward","family":"Rhone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Siu Pan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surinder S.","family":"Birring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Silber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2017.12.011_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clim.2014.09.012","article-title":"Safety, efficacy, and pharmacokinetics\/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia\/lymphoma","volume":"155","author":"Berkowitz","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.msard.2017.12.011_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fimmu.2013.00437","article-title":"Granuloma formation in pulmonary sarcoidosis","volume":"4","author":"Broos","year":"2013","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2017.12.011_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1183\/09031936.05.00030805","article-title":"Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients","volume":"26","author":"Katchar","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.msard.2017.12.011_bib4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/thx.2010.155762","article-title":"Sarcoidosis complicating treatment with natalizumab for Crohn's disease","volume":"66","author":"Parisinos","year":"2011","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.msard.2017.12.011_bib5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.msard.2017.12.011_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1752-1947-7-270","article-title":"Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-\u03b2-1b: a case report","volume":"7","author":"Sahraian","year":"2013","journal-title":"J. Med. Case Rep."},{"issue":"4","key":"10.1016\/j.msard.2017.12.011_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2141.2007.06687.x","article-title":"The development of sarcoidosis with the use of alemtuzumab \u2013 clues to T-cell immune reconstitution","volume":"138","author":"Thachil","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.msard.2017.12.011_bib8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/cyto.b.20120","article-title":"Prognostic value of neutrophils and NK cells in bronchoalveolar lavage of sarcoidosis","volume":"70","author":"Tutor-Ureta","year":"2006","journal-title":"Cytom. B Clin. Cytom."},{"key":"10.1016\/j.msard.2017.12.011_bib9","unstructured":"Villalba, M.L., 2016. Center for Drug Evaluation and Research Medical Review(s). Application Number 761029Orig1s000, Reference ID: 3906449."},{"key":"10.1016\/j.msard.2017.12.011_bib10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrneurol.2013.95","article-title":"Modulation of IL-2R\u03b1 with daclizumab for treatment of multiple sclerosis","volume":"9","author":"Wiendl","year":"2013","journal-title":"Nat. Rev. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034817303498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034817303498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:41:23Z","timestamp":1761900083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034817303498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":10,"alternative-id":["S2211034817303498"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2017.12.011","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Sarcoidosis in a patient with Multiple Sclerosis on daclizumab monotherapy","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2017.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}